Company intelligence
AQUAPASS
Non-Invasive, Kidney Independent Fluid Overload Treatment System
Medical Equipment Manufacturing
Newton, US
21 employees
Founded 2019
1 public signals
About AQUAPASS
AQUAPASS is the developer and manufacturer of innovative solutions for the treatment of fluid overload and congestion in acutely decompensated heart failure patients, end-stage kidney disease (ESKD) chronic kidney disease, and lymphedema patients. The treatment is non-invasive and bypasses the renal system. It is intended to be used in the hospital or the outpatient clinic. Initial clinical trials confirmed the safety and performance of the system in acute heart failure (CHF) patients and in end-stage renal disease (ESRD) patients. We are currently enrolling in our REFORM-HF FDA pivotal trial.
Verified activity
Signals from AQUAPASS
1 published signal